Health Condition 1: null- Adult male or female patients with mild to moderate plaque type psoriasis.
Conditions
Interventions
Intervention1: AKBBA capsules: One capsule twice a day for 90 days.
Intervention2: AKBBA topical cream: One fingertip unit on the affected area, thrice a day for 90 days.
Sponsors
Sami Labs Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients with Mild to Moderate plaque type psoriasis excluding co-morbid conditions. 2 Chronic plaque type psoriasis or stable psoriasis. 3 Willing to sign on Informed consent form.
Exclusion criteria
Exclusion criteria: 1 Patients who have more than 50 percent of body surface area covered by psoriasis lesions. 2 Patients on anticoagulant therapy. 3 Use of immunosuppressive medication within past 2 months. 4 Presence of other skin lesions (actinic ketoses or lentigo) or photo damaged skin 5 Use of systemic or intra lesional therapy or photo (chemo) therapy for psoriasis in the previous two months. 6 Concomitant bacterial, fungal, or viral skin infections. 7 Pregnant or sexually active women who do not use contraception. 8 Non-adherence to the treatment. 9 Have history of renal, hepatobiliary, or malignant disease, hypertension or recurrent acute infection 10 History of any other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 PASI Scoring. 2 Clinical Photographs. 3 Global Evaluation by the Doctor. 4 Global Evaluation by the Patient. 5 Psoriasis global assessment. 6 Biomarkers.Timepoint: 1 PASI Scoring,Global Evaluation by Doctor and Patient(Day0,Day30,Day60 & Day90). 2 Clinical Photographs(Screening,Day0,Day30,Day60 & Day90). 3 Biomarkers(Day0 & Day90). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Adverse Events.Timepoint: Day0,Day30,Day60 & Day90. | — |
Countries
India
Contacts
Public ContactMs Prachi Lad
ClinWorld(P)Limited
Outcome results
None listed